Reports for STERIMAX INC
Company Name
STERIMAX INC
Totals |
||
Shortage reports |
116 |
|
| Actual shortage: | 16 (14%) | |
| Anticipated shortage: | 2 (2%) | |
| Avoided shortage: | 2 (2%) | |
| Resolved: | 96 (83%) | |
Discontinuation Reports |
5 |
|
| To be discontinued: | 5 (100%) | |
| Discontinued: | 0 (0%) | |
| Reversed: | 0 (0%) | |
Late reports |
28 (23%) |
|
Overdue reports |
4 (17%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ONDANSETRON INJECTION USP | 2MG | SOLUTION | Resolved | 2023-01-19 | 2023-03-07 | 181875 |
| GLYCOPYRROLATE INJECTION USP | 0.4MG | SOLUTION | Resolved | 2023-01-19 | 2023-04-17 | 181847 |
| PHENYLEPHRINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | Resolved | 2023-01-19 | 2023-02-22 | 181836 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP | 10G | POWDER FOR SOLUTION | Resolved | 2022-12-13 | 2023-01-06 | 178276 |
| GLYCOPYRROLATE INJECTION USP | 4MG | SOLUTION | Resolved | 2022-12-06 | 2023-02-02 | 177192 |
| PHENYLEPHRINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | Resolved | 2022-11-07 | 2022-12-13 | 173923 |
| GLYCOPYRROLATE INJECTION USP | 0.2MG | SOLUTION | Resolved | 2022-09-14 | 2023-01-19 | 169242 |
| FUROSEMIDE INJECTION USP | 10MG | SOLUTION | Resolved | 2022-06-27 | 2022-08-05 | 163468 |
| CALCIUM CHLORIDE INJECTION BP | 100MG | SOLUTION | Resolved | 2022-06-15 | 2022-08-05 | 162674 |
| CEFTAZIDIME FOR INJECTION BP | 6G | POWDER FOR SOLUTION | Resolved | 2022-06-09 | 2022-07-12 | 162221 |
| CEFTAZIDIME FOR INJECTION BP | 2G | POWDER FOR SOLUTION | Resolved | 2022-06-09 | 2022-07-15 | 162210 |
| CEFTAZIDIME FOR INJECTION BP | 1G | POWDER FOR SOLUTION | Resolved | 2022-06-09 | 2022-07-12 | 162207 |
| BACIJECT | 50000UNIT | POWDER FOR SOLUTION | Resolved | 2022-06-09 | 2022-09-10 | 162204 |
| FENTANYL INJECTION BP | 100MCG | SOLUTION | Resolved | 2022-05-17 | 2022-11-04 | 160700 |
| CALCITRIOL INJECTION USP | 1MCG | SOLUTION | Resolved | 2022-03-03 | 2022-09-10 | 155959 |
| ONDANSETRON INJECTION USP | 2MG | SOLUTION | Resolved | 2022-03-03 | 2022-04-09 | 155955 |
| ONDANSETRON INJECTION USP | 2MG | SOLUTION | Resolved | 2022-03-03 | 2022-04-09 | 155950 |
| TOBRAMYCIN INJECTION USP | 40MG | SOLUTION | Resolved | 2022-03-03 | 2022-09-10 | 155947 |
| HYDROMORPHONE HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2022-02-17 | 2022-03-04 | 155221 |
| REMIFENTANIL HYDROCHLORIDE FOR INJECTION | 2MG | POWDER FOR SOLUTION | Resolved | 2022-02-01 | 2022-09-27 | 153969 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PHENYLEPHRINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | To be discontinued | 2024-03-22 | 2024-03-22 | 223145 |
| PHENYLEPHRINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | To be discontinued | 2024-03-22 | 2024-03-22 | 223140 |
| MYCOPHENOLATE MOFETIL FOR INJECTION USP | 500MG | POWDER FOR SOLUTION | To be discontinued | 2024-01-22 | 2024-02-06 | 216963 |
| BUPIVACAINE HYDROCHLORIDE INJECTION, USP | 7.5MG | SOLUTION | To be discontinued | 2024-01-15 | 2024-01-15 | 216017 |
| STREPTOMYCIN FOR INJECTION USP | 1G | POWDER FOR SOLUTION | To be discontinued | 2023-11-06 | 2023-11-06 | 209235 |
Showing 1 to 5 of 5